-
-
-
-
-
-
-
Exact Sciences (EXAS) Guides Q4 Revenue of $551-$553M
-
-
-
-
-
-
-
Exact Sciences Announces Preliminary Fourth Quarter 2021 Results
-
-
-
-
-
-
-
Exact Sciences Announces Second Quarter 2021 Results
-
-
-
-
-
-
-
Exact Sciences to Acquire Ashion Analytics and Enter Research Collaboration with City of Hope's Genomics Institute, TGen
-
-
-
-
-
-
-
Exact Sciences to participate in November investor conferences
-
-
-
-
-
-
-
Exact Sciences Announces Entry into Agreements to Sell $869 Million of Common Stock in Registered Direct Offering
-
-
-
-
-
-
-
10x Genomics Appoints Kim Popovits to Board of Directors
-
923,810 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All